IJCP Group's journey from one medical journal to a leading healthcare communications group

IJCP Group started its journey in June 1990 with its flagship medical journal, the
Indian Journal of Clinical Practice, with a brilliant editorial team comprising of
doctors and research analysts. Very soon, IJCP grew from this one journal to a Group
of Publications. Today, IJCP’s network has traversed borders to win appreciation by
the doctors from the different parts of the world.
With a wide range of publications, Events & PR, audio & visual, and host of other
information packed products, IJCP Group is the preferred partner of not only the
Medical fraternity but also the Pharmaceutical companies.
But the journey of IJCP does not end here…. We believe this is the beginning of
our journey…..

Contact us

Head Office Dr Veena Aggarwal Mr Nilesh Aggarwal
IJCP Publications Pvt. Ltd. Group Executive Editor & Director
E-219, Greater Kailash Part - I Joint Managing Director 09818421222
New Delhi - 110048 09811036687

Our Management

Dr KK Aggarwal
Padma Shri & Dr B C Roy Awardee
CMD, Publisher and Group Editor-in-Chief
President, Heart Care Foundation of India
emedinews@gmail.com

Dr KK Aggarwal is a Senior Consultant Physician and Cardiologist and Dean of the
Board of Medical Education Moolchand Medcity, New Delhi. He is the Founder,
Trustee and President of Heart Care Foundation of India.
Dr. KK Aggarwal has received many prestigious awards, including the Padma Shri
and Dr. B C Roy National Award from the 12th President of India, Smt. Pratibha
Devisingh Patil, for his unique contributions in the health sector. He is also known
as a writer, columnist and expert for newspapers and TV shows.

Dr. Mrs. Veena Aggarwal
Group Executive Editor & Joint Managing Director
Director, Heart Care foundation of India
drveenaijcp@gmail.com

Dr Veena Aggarwal, besides being a Consultant in Holistic and Antenatal Care, is a
Clinical Obstetrician and Gynecologist by profession.
Under her dynamic leadership, foresight and quest for perfection, the IJCP
Group has crossed many a milestone and is today a leading healthcare
communications group.

Journal
Indexed with IndMED
www.ijcpgroup.com ISSN 0971-0876 Single Copy Rs. 250/-

Indian Journal of

CLINICAL
IJCP

PRACTICE
Volume 21, Number 7
R
ev
w
Jo
ie

u
al
rn 361-420 Pages December 2010
er
Pe

Esophageal Ulceration Following
Typhoid Fever

Dr KK Aggarwal
Group Editor-in-Chief

Indian Journal of Clinical Practice

The flagship journal of IJCP Group of
From the Desk oF Group eDitor-in-ChieF
From the Desk oF Group eDitor-in-ChieF Publications was launched in June 1990
ACS Updates Prostate Cancer Screening Guideline
as a monthly medical journal to provide
an insight into the proper diagnosis and
treatment of diseases and conditions
commonly encountered by an Indian
physician. IJCP is unquestionably India’s
Dr KK Aggarwal
Padma Shri and Dr BC Roy National Awardee
leading medical journal.
Sr Physician and Cardiologist, Moolchand Medcity
Group Editor-in-Chief, IJCP Group
Editor-in-chief, eMedinewS
Chairman Ethical Committee, Delhi Medical Council
Director, IMA AKN Sinha Institute (08-09)
Hony. Finance Secretary, IMA (07-08)
Chairman, IMA AMS (06-07)
President, Delhi Medical Association (05-06)
emedinews@gmail.com

Specifications
http://twitter.com/DrKKAggarwal
Krishan Kumar Aggarwal (Facebook)

T
he American Cancer Society (ACS) has updated its prostate cancer screening guideline. Men should only
be screened after they receive information about the uncertainties, risks, and potential benefits associated
with prostate cancer screening.
 Size: A4
 Prostate-specific antigen (PSA) testing is now recommended with or without the digital rectal exam (DRE).
 There is little evidence that the DRE adds significant benefit to the PSA test, except, perhaps, when the PSA
is in the borderline range.  Pages: 56+4
 PSA value of 4.0 ng/ml be used as a reasonable threshold to trigger further evaluation.
 There is a new recommendation for men with PSA values between 2.5 and 4.0 ng/ml. Twenty-five percent
of men with PSA levels between 2.5 and 4.0 ng/ml harbor prostate cancer and physicians should consider an  Printing: 4+1 Color
individualized risk assessment for these men.

 Paper: 210/90 GSM Indian Art Paper
 An individual assessment should take into account non-PSA risk factors, such as race, family history, results
of previous biopsies and DRE results.
 ACS also now recommends that the PSA testing interval be reduced to every other year for men whose PSA
level is under 2.5 ng/ml. Such a reduction in testing frequency will lead to significantly reduced false positives,
unnecessary biopsies and overdiagnosis, with only a negligible increase in missed cancers.
Source: CA Cancer J Clin Published online March 3, 2010.
 Frequency: Quarterly
n n n
 Readership: 50,000
 Cover Price: ` 300/-
Indian Journal of Clinical Practice, Vol. 21, No. 9, February 2011 485

Annual Subscription: ` 3500/-

IJCP’s Medinews
Launched in June 1992, Medinews is
Controlled-Release Tramadol in Chronic Pain India’s first and most comprehensive
C hronic pain is different from acute pain. It can be
multifactorial; often it may not be possible to find out if Advantages of CR Tramadol
medical newspaper.
it is nociceptive, neuropathic, idiopathic or all of the above, • Extended duration of action for reduced dosing

Medinews features healthcare news as
which in turn affects the duration and treatment.1 More frequency
than 40-50% of patients in routine practice settings fail to
• More constant plasma concentrations for improved
achieve adequate relief making chronic pain a particular
efficacy and tolerability
challenging problem to treat. Besides its impact on quality-
of-life (QOL), chronic pain incurs great healthcare costs.2
Available analgesics include nonopioids such as
• Improved compliance and therapeutic outcomes

The bioavailability of the CR tramadol formulation is
an unbiased and well reasoned analysis
and covers medical events, nationally
acetaminophen, nonsteroidal anti inflammatory drugs
(NSAIDs), cyclo oxygenase-2 (COX-2) inhibitors, weak comparable with IR (immediate release) formulations,
opioids such as codeine and tramadol and conventional with a half-life 3-4 times longer (16 hours vs 4-6 hours)
opioids such as oxycodone and morphine.3 NSAIDs and and an extent of absorption similar to IR tramadol given

and internationally in a well-illustrated
acetaminophen are the cornerstone of treating most pain thrice-daily.11
conditions. But, their analgesic efficacy varies widely among Tramadol has been widely studied in the treatment of chronic
individual patients. Gastrointestinal toxicity is present in pain, such as osteoarthritis, low back pain, cancer pain and
50% of NSAIDs users and 5.4% develop a more serious
event requiring hospitalization due to their frequent use.4
NSAIDs may have a possible deleterious effect on articular
neuropathic pain.6 CR tramadol is shown to be more effective
in terms of analgesia compared to standard formulation of
tramadol both six and 12 hours after administration. It also
format. Medinews has enjoyed the
OFFICIAL PRESS status at premium
cartilage metabolism.5 They may affect fluid and electrolyte has fewer adverse effects than the standard formulation.12
balance, causing fluid retention, edema and hypertension.6 A double-blind crossover comparative study has reported
Most patients above 65 years have multiple co-morbid disease significant improvement in pain intensity with CR tramadol
conditions such as heart disease, diabetes, hypertension, as compared with IR tramadol and higher patient-rated
Alzheimer’s and renal disease that significantly complicate
treatment of pain.3
treatment effectiveness.13 CR tramadol therefore provides
the advantage of around-the-clock analgesic control with
reduced dosing frequency which is essential to obtain patient
National conferences like APICON, CSI,
Tramadol, an Atypical Opioid Analgesic
Tramadol is a synthetic, centrally acting analgesic that has
compliance in conditions of chronic pain.

CR Tramadol in Osteoarthritis
AICOG, PEDICON, IMA-CON, IADVL and
been used to treat pain effectively in a variety of indications.7
It belongs to the second step of the WHO analgesic ladder.
Tramadol has an atypical pharmacological profile with
both opioid and monoaminergic mechanisms. It exerts its
A chronic degenerative disorder of multifactorial
etiology, osteoarthritis (OA) is the second most common
rheumatological problem and is the most frequent joint
NAPCON for the last 5 years.
analgesic effects by complementary mechanisms of action: disease with prevalence of 22-39% in India. Pain along with
It binds weakly to µ-receptors and inhibits ascendent pain functional limitation and stiffness are the major symptoms
transmission pathways in the spinal cord. At the same time, making OA the most common cause of locomotor disability
it stimulates descendent inhibitory pathways by increasing in the elderly.4 Effective pain control is one of the goals
release and decreasing re-uptake of noradrenaline and

Specifications
of treatment,5 which depends on the analgesic efficacy of
serotonin.8 The (+) enantiomer is more potent than the treatment and compliance with the dosing regimen.7
the (–) enantiomer in inhibiting serotonin reuptake. On the
other hand, the (–) enantiomer is more potent in inhibiting CR tramadol is an efficacious and well-tolerated medication
norepinephrine reuptake and increasing presynaptic release. for the treatment of OA pain.11 The American Pain Society
This differential interaction between the two enantiomers is recommends tramadol for the management of OA pain
synergistic.6 The dual mechanism of action gives tramadol when NSAIDs alone produce inadequate pain relief.11 The

Size: A4 Size
recommendations of the American Heart Association include

an efficacy that is equivalent to codeine, despite a 10-fold
lower affinity to µ-receptors.8 Tramadol does not have tramadol, not NSAIDs or COX-2-specific inhibitors, as
the typical opioid adverse effects at the respiratory and first-line therapy for musculoskeletal symptoms in patients
cardiovascular level and on intestinal motility at therapeutic with cardiovascular disease or risk factors.6

Pages: 12+4/20+4
doses.9 In addition, it avoids the ulcerogenic, renal/cardiac/
hepatic adverse effects of NSAIDs and COX-2 inhibitors.
This feature combined with the lower potential for abuse
In a 12-week clinical trial of OA of the knee, CR formulation
of tramadol provided patients with increased control over
the management of their pain, fewer interruptions in sleep

or dependence, gives tramadol a significant advantage over and improved compliance.14 Clinical data on tramadol and

Paper: 70/130 GSM Indian Art Paper
nonopioids and also over conventional opioids, particularly

paracetamol indicate that both the parent drug (tramadol)
in the elderly.3 and its active metabolite achieved adequate concentrations in
Tramadol has a half-life of about 5.5 hours and the usual oral synovial fluid in comparison to paracetamol.15 The results of
dosage regimen is 50-100 mg every 4-6 hours (maximum a long-term open label study demonstrated that CR tramadol

 Printing: 4 Color
dose: 400 mg/day). To reduce the frequency of administration is effective for the long-term management of OA pain.
and to improve patient compliance, a controlled-release Reductions in pain intensity, improvements in sleep
(CR) formulation of tramadol has been developed.10 and functionality and most QOL measures reported in

 Readership: 1,00,000
 Frequency: Monthly
 Cover Price ` 100/-
Advertisement Tariff Annual subscription ` 1200/-

Position Dimension (H X W/Cm.) Amount (`/Advt.)
Front Solus 15 x 10 ` 40,000
Back Solus 22 x 34 ` 35000
Full Page ` 40,000/-
RHS Pages Economy 15 x 10 ` 30,000/-
LHS Pages Economy 15 x 10 ` 25,000/-

Journal

Peer Review Journal ISSN 0972-70035 Single Copy Rs. 250/-
www.ijcpgroup.com

Volume 13, Number 8, December 2010, Pages 197-236

Dr KK Aggarwal Dr Praveen Chandra
Group Editor-in-Chief Guest Editor

Asian Journal of Clinical Cardiology

Asian Journal of Clinical Cardiology (AJCC)
From the Desk oF Group eDitor-in-ChieF
xxxxxxxxxxx
is an ambitious attempt by IJCP Group
New Test to Predict Cardiac Risk in Healthy
Patients to publish a journal of international
standards.
Highly sensitive assay for cardiac troponin T (cTnT) can predict cardiovascular events in apparently healthy
populations. As part of the Dallas Heart Study, cTnT levels were measured using both standard and highly
sensitive assays in more than 3,500 patients ages 30 to 65. The results were published in the Dec. 8 Journal of
Dr. Praveen Chandra, Interventional
Cardiologist, Medanta Medcity is the Editor
the American Medical Association 2010. The standard assay found detectable cTnT in only 0.7% of the study
participants, while the highly sensitive test found it in 25%. Only 7.5% of people in the lowest cTnT group
had left ventricular hypertrophy compared to 48.1% in the highest cTnT group. Mortality also increased from
1.9% in the lowest group to 28.4% in the highest. cTnT was independently associated with all–cause mortality
(adjusted hazard ratio, 2.8 in the highest cTnT group). of the journal. Dr Chandra and a network
of eminent Indian and international
Another study in the same issue tested the highly sensitive cTnT assay’s ability to predict heart failure in more than
4,000 community–dwelling elderly patients. The biomarker was detectable in the majority of patients (66.2%)
and associated with an increased risk of heart failure and cardiovascular death at higher concentrations (4.8 deaths
per 100 in highest group compared to 1.1 in patients with undetectable levels). This study continued cTnT
measurements over time and found that increases of more than 50% were also associated with cardiovascular cardiologists are toiling tirelessly to make
events.
In both studies, there was significant overlap between cTnT and N–terminal pro–brain–type natriuretic peptide,
suggesting that more accurate predictions may be achieved by use of both tests together.
AJCC a world class cardiology journal.

Specifications
 Size: A4
 Pages: 36+4
Dr KK Aggarwal

 Printing: 4+1 color
Editor-in-Chief, eMedinewS

emedinews@gmail.com

 Frequency: Monthly

Asian Journal of Clinical Cardiology, Vol. 13, No. 9, January 2011 237

 Cover Price ` 300/-
Annual Subscription ` 3500/-

Journal

Editorial

Volume : 1 January-March 2011

Indian Journal of Clinical Practice, Vol. 20, No. 6, November 2009

Asian Journal of Obstetrics Gynecology

From the desk oF group editor-in-chieF
Asian Journal of Obs Gynae Practice was
Paracetamol for Fever in Pregnancy launched in December 1996 as the first
of the series of specialized journals under
the ‘Asian Series’. The journal covers a
Dr KK Aggarwal
whole range of topics in the specialty,
from antenatal care to general gynecology
to operative obstetrics including its
emedinews@gmail.com subspecialities of Urogynecology, Oncology
http//twitter.com/DrKKAggarwal
and Reproductive Endocrinology.
E
levation of maternal core temperature from a febrile illness or other source (e.g. hot tub) in the first
trimester of pregnancy may be associated with an increased risk for neural tube defects or miscarriage.
The National Birth Defects Prevention Study, however observed that among women with infection-related
fever, use of paracetamol was associated with a statistically significant reduction in neural tube defects, as well as
Dr Alka Kriplani, Professor, Dept. of
cleft lip/palate and gastroschisis. The data support the safety of paracetamol for relief of fever and pain; however,
the reduction in birth defects should be confirmed in other studies before the drug can be recommended to febrile Obstetrics and Gynecology, AIIMS, is the
women for this purpose.

Evidence Editor of the journal.
To investigate whether exposure during the first trimester of pregnancy to single-ingredient acetaminophen
increases the risk of major birth defects. Data from the National Birth Defects Prevention Study, a population-
based, case-control study, were used. Women who delivered between January 1, 1997, and December 31, 2004

Specifications
and participated in the telephone interview were included. Type and timing of acetaminophen use were assigned
based on maternal report. Women reporting first-trimester acetaminophen use in a combination product were
excluded, resulting in a total of 11,610 children in the case group and 4,500 children in the control group
for analysis. The prevalence of first-trimester single-ingredient-acetaminophen use was common: 46.9%
(n = 5,440) among women in the case group and 45.8% (n = 2,059) among women in the control group

(p = 0.21). Overall, acetaminophen was not associated with an increased risk of any birth defect. Among women
reporting a first-trimester infection and fever, use of acetaminophen was associated with a statistically significantly
decreased odds ratio (OR) for an encephaly or craniorachischisis (adjusted OR 0.35, 95% confidence interval
[CI] 0.08-0.80), encephalocele (adjusted OR 0.17, 95% CI 0.03-0.87), anotia or microtia (adjusted OR 0.25,
95% CI 0.07-0.86), cleft lip with or without cleft palate (adjusted OR 0.44, 95% CI 0.26-0.75) and gastroschisis
(adjusted OR 0.41, 95% CI 0.18-0.94).
 Size: A4
Single-ingredient-acetaminophen use during the first trimester does not appear to increase the risk of major
birth defects. It may decrease the risk of selected malformations when used for a febrile illness.  Pages: 48+4
Source: Feldkamp ML, Meyer RE, Krikov S, Botto LD. Obstet Gynecol 2010;115(1):109-15.
n n n

Asian Journal of Obs and Gynae Practice, Vol. 1, January-March 2011
Annual subscription ` 1200/-

Asian Journal of Diabetology

From the Desk oF Group eDitor-in-chieF The Asian Journal of Diabetology is a
Changing Practice Guidelines: A1C prestigious quarterly journal. Dr Vijay
Vishwanathan, an eminent Diabetologist,
Managing Director, MV Hospital for
Diabetes and Diabetes Research Center,
Chennai is the Editor of the journal.
Dr KK Aggarwal
Padma Shri and Dr BC Roy Awardee
The journal focuses on informing
Physicians and Diabetologists about
Member, Delhi Medical Council
Hony. Finance Secretary, IMA (07-08) managing various aspects of diabetes
drkk@ijcp.com to provide better patient care to
India’s continually rising population of
T diabetics.
he American Diabetes Association (ADA), the International Diabetes Federation (IDF) and the European
Association for the Study of Diabetes (EASD) have joined forces to recommend the use of the hemoglobin
A1C assay for the diagnosis of diabetes.
A1C values vary less than FPG (fasting plasma glucose) values and the assay for A1C has technical advantages
compared with the glucose assay. A1C gives a picture of the average blood glucose level over the preceding

Specifications
2-3 months.
A1C has numerous advantages over plasma glucose measurement:
 It is a more stable chemical moiety.
 The patient does not need to fast.

Readership: 5,000
Measuring A1C is more convenient and easier for patients who will no longer be required to undergo a fasting


or oral glucose tolerance test (OGTT).
 It correlated tightly with the risk of developing retinopathy.

Size: A4
The committee has determined that an A1C value of 6.5% or greater should be used for the diagnosis of diabetes.
This cut-point, is where risk of retinopathy really starts to go up. 
Avoid using estimated average glucose, or EAG, as this is just a way to convert the A1C into glucose levels.
Source: American Diabetes Association (ADA) 69th Scientific Sessions. Presented June 5, 2009. Diabetes Care Published online June 5, 2009.
 Pages: 36+4

Asian Journal of Diabetology, Vol. 12, No. 1, January-March 2010



Journal

Volume 6, Number 3 July-September 2010

Sedation Practices for the Patient in
the ICU

Should C-reactive Protein
Concentration at ICU Discharge be
Used as a Prognostic Marker?

Clostridium Difﬁcile: Moving Beyond
Antimicrobial Therapy

ICU Intubation Success Hampered by
Non-ideal Conditions: Based on Small
Cohort Study...

Pain Not Minimized after Minimally
Invasive Cardiac Surgery

Still Asleep at the (Ventilator) Switch?

Timing of Tracheotomy Linked to
Length of Stay: Study Finds to Effect
on Mortality from Early Procedure

more...

Asian Journal of Critical Care

From the desk oF Group editor-in-chieF
Today, the demands on the intensivists
Nonresolving Pneumonia are tremendous, making it necessary for
them to be updated with the latest in the
field.
In view of this, IJCP has another specialty
journal, Asian Journal of Critical Care. It
discusses original research, review articles,
Dr. KK Aggarwal
Dr BC Roy Awardee technology in medicine for physicians
Sr Physician and Cardiologist Moolchand Medcity
Group Editor-in-Chief, IJCP Group and allied health professionals involved
Hony. Finance Secretary, IMA (0�-08)
Chairman, IMA AMS (06-0�)
in treating the critically ill with the aim
drkk@ijcp.com to improve patient care.

S
low or incomplete resolution of pneumonia despite treatment is a common clinical problem, estimated to
be responsible for approximately 15% of inpatient pulmonary consultations and 8% of bronchoscopies.1
Normal resolution of pneumonia is not easily defined. Patients typically note subjective improvement within
Specifications
3-5 days of treatment; more specific clinical criteria for resolution include improvement in fever, cough, crackles,
leukocytosis, arterial oxygenation (PaO2) and level of C-reactive protein.2
Most studies on the natural history of pneumonia have focused upon the resolution of chest radiographic  Size: A4
abnormalities, with ‘slow resolution’ often being defined as the persistence of radiographic abnormalities for
greater than one month in a clinically improved host.
The diagnostic evaluation of treatment failure in pneumonia should begin with a careful history, physical  Pages: 36+4
examination, and review of the clinical picture.
One should first consider whether or not the rate of resolution is within the range of expected norms depending
on the patient’s underlying host factors, comorbidities, severity of illness and suspected pathogens. In stable or  Printing: 4+2 color
slowly improving pneumonia, especially in the presence of comorbidities or host factors which are known to delay

the resolution of pneumonia, careful observation with or without therapy is warranted for 4-8 weeks.3
When needed, further evaluation should include chest CT to look for sequestered areas of infection or for findings 
that suggest an alternative diagnosis. When pneumonia fails to resolve or when there is clinical progression,

Frequency: Quarterly
fiberoptic bronchoscopy should be considered.

Asian Journal of Critical Care Vol. 5, No. 4, October-December 2009

 Price: ` 300/-

Journal

July-September 2010

Asian Journal of Paediatric Practice

From the desk oF group editor-in-chieF From preventive health care to treatment
Smokers in the House, a Risk Factor for of childhood diseases to emergency care
Hospitalization of Children with Flu and adolescence – all these subjects and
Dr KK Aggarwal
many more are covered in the much
appreciated and read Asian Journal of

Paediatric Practice.

Under the able guidance of Dr Swati
emedinews@gmail.com

A Bhave, Executive Editor, Association of
large retrospective case-control study reported at the annual meeting of the Infectious Diseases Society of
America (IDSA) says that having smokers in the house increases the possibility of a young child with flu
needing inpatient care.
Data from more than 1,300 laboratory-confirmed cases of children with influenza, collected by 10 sites in the
CDC’s Emerging Infections Program in 2005-2008 were analyzed to identify risk factors for hospitalization
Adolescent Child Care in India (AACCI),
associated with laboratory-confirmed influenza.
Analysis showed that if more than half of household members were smokers it doubled the chances a child would
the journal serves as a practical guide for
have a serious case of flu. According to Nila Dharan, MD, of the division of infectious diseases at the NYU School
of Medicine in New York City, a family member who had been vaccinated against flu was protective, even if the the continuing education of Pediatricians
child was not fully protected by immunizations. The study included 290 children ages six to 59 months (median
age 20 months) with serious cases of flu; 1,089 age- and zip code-matched children with the flu who did not need
inpatient care during the three influenza seasons acted as controls. The salient observations were as below.
and Neonatologists.
Age of the mother: if ≤26 years, the odds were doubled. The odds ratio (OR) was 2.1, with a 95% confidence
interval (CI) from 1.3 to 3.4. The risk was increased if the child’s vaccinations were not up-to-date. The OR was
1.7, with a 95% CI from 1.1 to 2.7.
If more than half of household members smoked, the child’s risk of needing inpatient care was doubled. The OR Specifications
was 2.3, with a 95% CI from 1.0 to 5.3. The risk was similar to having any pulmonary condition, including
asthma.
If the child was not fully vaccinated for the flu, having any household member immunized was protective.
The OR was 0.5, with a 95% CI from 0.3 to 0.8.  Readership: 20,000
Underlying medical conditions also had an important role; presence of a hematologic or oncologic condition
increased the risk by a factor of 12.
According to Dr Dharan, other researchers have examined a possible association between exposure to smoking and
 Size: A4
a child’s risk of needing inpatient care for flu, but this is the largest study to date.
n n n  Pages: 36+4
Asian Journal of Paediatric Practice, Vol. 14, No. 1  Paper: 170/90 GSM Indian Art Paper
 Price: ` 300/-

Journal

October-December 2010

Asian Journal of Ear, Nose Throat

The management of diseases and the
from the Desk of group eDitor-in-chief

New Daily Persistent Headache latest techniques in the subspecialties of
Otology, Rhinology and Laryngology need
to be discussed and informed at length
under a common platform efficiently
provided by the Asian Journal of Ear,
Dr KK Aggarwal
Nose Throat.
Padma Shri and Dr BC Roy Awardee

It provides worldclass information to
Sr Physician and Cardiologist Moolchand Medcity
Chief Editor, eMedinewS
Indian ENT practitioners under the
guidance of its founder Editor, Dr VP Sood,
President, Delhi Medical
Association (05-06)
drkk@ijcp.com

Secretary-cum-Managing Trustee, Dr Sood
N Nasal Research Foundation, Past President
ew daily persistent headache (NDPH) is a primary headache disorder in which headache begins one
day and does not remit, in an individual without a headache history. The pathophysiology is poorly
understood. Onset of NDPH can be triggered by certain events, such as infection.
The incidence and prevalence of NDPH are unknown, but is rare. It is more frequent in children than in adults,
and affects women more often than men. A characteristic feature is that the headache starts abruptly and is
Association of Otorhinolaryngologists.
daily and unremitting from, or almost from, the moment of onset, typically in individuals without a prior
headache history.

Specifications
The diagnosis is clinical and requires ruling out secondary causes. Current diagnostic criteria exclude patients
with predominant migrainous features, many headache experts contend that the diagnosis of NDPH can be
made regardless of the presence of migrainous features. For patients with recent onset of suspected NDPH, one
should do neuroimaging upon presentation. A lumbar puncture is indicated if clinical features suggest a possible
central nervous system infection or idiopathic intracranial hypertension.

Readership: 20,000
The differential diagnosis includes a number of secondary and primary causes of headache. It is particularly
important to consider cerebral venous sinus thrombosis, headache secondary to spontaneous cerebrospinal fluid
leaks, idiopathic intracranial hypertension (pseudotumor cerebri), and giant cell arteritis.

NDPH may take either of two subtypes: a self-limited one, or a persistent form which can last years or decades
and is challenging to treat.  Size: A4
For patients with primary NDPH, first classify the phenotype of NDPH as most similar to either migraine or
tension-type headache, and then treating with appropriate preventive headache therapy accordingly.

n n n
 Pages: 36+4
Asian Journal of Ear, Nose Throat, April-June 2010
 Price: ` 300/-

Indian Journal of Medilaw

From thE dEsk oF group Editor-in-ChiEF There has been a considerable increase
Editorial
Driving Restrictions for Patients with Seizures in medicolegal cases in India in the
KK Aggarwal
past few years. This rise in medical law
litigations is due to Consumer Protection
Act (CPA) and awareness about protection
of patients’ rights and consistent public
Dr KK Aggarwal
demands for professional accountability.
It is also a fact that, there are no apparent
Hony. Finance Secretary, IMA (07-08) and explicit guidelines in this regard.
emedinews@gmail.com
The Indian Journal of Medilaw was
launched with the objective to keep the
Indian Doctors updated about the current
The seizure-free interval is the most practical and widely used measure of a patient’s driving risk.
laws and implications on their practice.


 Longer seizure-free intervals (6-12 months) are associated with reduced risk of seizure-related motor vehicle
accidents (MVA).
 Shortening seizure-free intervals to three months by some states has not been associated with increased
MVAs.
 High seizure frequency, medical noncompliance, a history of MVAs and other factors increase the risk of
seizure-related MVA. These should be considered to extend the seizure-free interval requirement for driving
Specifications
recommendations.
An established pattern of purely nocturnal seizures, consistent and reliable seizure auras, clear provocation,
Size: A4


or acute symptomatic seizures in a condition that is not associated with epilepsy or is unlikely to recur may
reduce the seizure-free interval requirement.

Pages: 36+4
Doctors should also consider other neurologic contraindications for driving in their patients with epilepsy,



including impaired cognition and visual field defects.
 The Epilepsy Foundation is a good resource for the current state specific rules on driving and epilepsy.


(www.epilepsyfoundation.org/living/wellness/transportation/driverlicensing.cfm)
Doctors should discuss driving with patients and record this discussion in the medical record. This discussion  Printing: 4+2 color
should include the risk of driving.

Indian Journal of Medilaw, September-November 2010
 Quantity: 2-10,000.
 Price: ` 300/-

IJCP International Journals

American Family Physician Indian Edition
A peer-reviewed journal of the American Academy of Family Physicians November-December, 2006

Diagnosis and  Diagnosing Rhinitis: Allergic vs.
Nonallergic
Treatment of Community-  Assessment of Microscopic Hematuria in
Acquired Tuberculosis Adults
 Diagnosis and Treatment of Chlamydia
trachomatis Infection
 Diagnosis and Treatment of Neisseria
gonorrhoeae Infections
 Diagnostic Approach to Pleural Effusion in
Adults
 Hepatitis A
 Management of Hip Fracture:
With Best Compliments from The Family Physician’s Role

A Division of Pharmaceuticals Ltd.

IJCP American Family Physician

American Family Physician is the journal
Diagnosing Rhinitis:Allergic vs. Nonallergic of the American Academy of Family
DAVID M. QUILLEN, M.D., and DAVID B. FELLER, M.D.
University of Florida Family Medicine Residency Program, Gainesville, Florida Physicians (AAFP).
Allergic rhinitis, the most common type of rhinitis, generally can be
differentiated from the numerous types of nonallergic rhinitis through a
thorough history and physical examination. Allergic rhinitis may be The American Academy of Family
seasonal, perennial, or occupational. The most common cause of nonallergic
rhinitis is acute viral infection. Other types of nonallergic rhinitis include
vasomotor, hormonal, drug-induced, structural, and occupational (irritant) Physicians is one of the largest national
medical organizations, representing more
rhinitis, as well as rhinitis medicamentosa and nonallergic rhinitis with
eosinophilia syndrome. Since 1998, three large expert panels have made
recommendations for the diagnosis of allergic and nonallergic rhinitis.

than 94,000 family physicians, family
Allergy testing (e.g., percutaneous skin testing, radioallergosorbent
testing) is not necessary in all patients but may be useful in ambiguous
or complicated cases. (Am Fam Physician 2006;73:1583-90. Copyright

medicine residents, and medical students
© 2006 American Academy of Family Physicians.)

R
hinitis is an inflammation of the diagnosis of rhinitis. This report is intended nationwide. Founded in 1947, its mission
nasal mucosa. Associated clinical to be a complete evidence-based guideline
symptoms include excessive
mucus production, congestion,
on the diagnosis and management of allergic
rhinitis and asthma. The authors proposed
has been to preserve and promote the
science and art of family medicine and to
sneezing paroxysm, watery eyes, and nasal a new classification for allergic rhinitis,
and ocular pruritus. The differential arguing that the current subdivisions (i.e.,
diagnosis of rhinitis is extensive (Table 11). seasonal and perennial) were not
Allergic rhinitis is considered a systemic
illness and may be associated with
satisfactory. Traditionally, pollens and
molds were considered possible causes of ensure high-quality, cost-effective health
constitutional symptoms such as fatigue, seasonal allergic rhinitis. However, in some
malaise, and headache. It also may be a
comorbidity in patients with asthma,
places, such as California and Florida, these
allergens are present year-round. The WHO
care for patients of all ages.
eczema, or chronic sinusitis. Differentiating authors suggested a classification system
allergic rhinitis from other causes of rhinitis based on the symptoms of intermittent,
can be difficult because the diagnostic
criteria for various forms of rhinitis are not
persistent, mild, and moderate-severe
rhinitis.
IJCP holds the sole printing rights for
always clear-cut. Accurate diagnosis is
important because therapies that are
effective for allergic rhinitis (i.e.,
The third report2 was coordinated by
the Agency for Healthcare Research and
Quality (AHRQ) in collaboration with the
American Family Physician in India.
antihistamines and nasal corticosteroids) American Academy of Family Physicians
may be less effective for other types of and the AAAAI. Unlike the first two reports,

Specifications
rhinitis.2 the AHRQ report is not a clinical guideline
Since 1998, three expert panels1-3 have but an evaluation of the evidence on rhinitis.
published reviews of rhinitis. The first report1 The report did not identify any studies
was created by the American Academy of differentiating allergic rhinitis and
Allergy, Asthma, and Immunology (AAAAI) nonallergic rhinitis based on clinical
as a complete guideline for the diagnosis and symptoms, physical examination findings,
management of rhinitis.
The second report,3 coordinated by the
or associated comorbidities. The AHRQ
report noted that the treatment conclusions
 Size - A4
World Health Organization (WHO), focuses may have been biased because

Pages - 36+4
on allergic rhinitis and asthma but includes pharmaceutical companies supported many
an extensive section on the differential of the trials.2 
Printing - 4+2 printing
8

American Family Physician (Indian Edition) Volume 1, Number 4 October-December, 2006

 Paper- 170/90 GSM Indian Art Paper
 Binding: Center Stitch

Publishing Article in a Journal

Publishing Articles in a Journal
A scientific article, 4-6 pages long, can
be published in any of our journals
@ Rs 200,000/- per article inclusive
of compilation, editing, layouting and
Special Reprint 2009
printing subject to peer review/approval
Methylcobalamin, Pyridoxine and Nicotinamide in by the Editorial Board.
Diabetic Neuropathy: A Review
S Jayaram*, Akash Khobragade**, Deepak Langade†

ABstRAct
Diabetes is the most common etiological factor for peripheral neuropathy (PN). While conventional
theory says that prolonged hyperglycemia results in the complications associated with diabetes,
including neuropathy, a recent study found that PN can manifest even in individuals with abnormal
Journal Article Reprints
glucose tolerance, a prediabetic condition. A combination of methylcobalamin, pyridoxine and
nicotinamide thus has additive and synergistic effects on the damaged nerve in diabetic neuropathy
which protect the nerve from further damage, restore its structural and functional integrity and
cause a recovery of function.

Key words: Hyperglycemia, prediabetic, polyneuropathy, adenosylcobalamin, vitamin B6, nicotinic acid,

Specifications
myelin sheath, axon

Background incidence approaches 50% for patients with diabetes
Peripheral neuropathy (PN) is characterized by pain, for more than 25 years.1 A study conducted in South
numbness and tingling in the extremities and slow India to find the prevalence and risk factors, found
nerve conduction. It affects a significant percentage a PN prevalence of 19.1% among type 2 diabetics
of the Indian population and can be extremely
debilitating. Around 7% of patients usually have
attending the diabetic clinic. Neuropathy was
diagnosed if the vibratory threshold of the great toe
exceeded 25. The incidence of PN increases with
 Size: A4
neuropathy upon diagnosis of diabetes, and the
increase in age and duration of diabetes.2 Based on a

*Hon. Professor of Medicine
compilation of studies from different parts of the world,
the World Health Organization (WHO) has projected  Paper: 110 GSM Indian Art Paper
Bombay Hospital, Mumbai that the maximum increase in diabetes would occur in
**Resident India.3 Considering the large population and the high
†
Clinical Pharmacology, Ex-lecturer
Dept. of Pharmacology
Grant Medical College and Sir JJ Group of Hospitals
prevalence of diabetes, the burden of diabetes and it’s
complications in India would become enormous.  Printing: 4 + 2 color offset printing
Mumbai Pathophysiology of diabetic neuropathy
 Pages: 4/6/8 pages
Address for correspondence
Dr Deepak Langade Diabetes is the most common etiological factor for PN
503/E-7, Runwal Estate, Opp. Lawkim and it is also the most studied in terms of pathogenesis.
Ghodbunder Road, Thane (W), Mumbai - 400 607 While conventional theory says that prolonged
E-mail: drdgl@hotmail.com hyperglycemia results in the complications associated
June 2009

INDIAN JOURNAL OF CLINICAL PRACTICE l VOL. 20, NO. 1
 One full page Advertisement

Advertisement Tariff (Code A 20)
Position Dimension Amount

Cover Double Spread 24.5 × 39.5 ` 200,000

Gate Fold False Cover 24.5 X 17.5 ` 150,000

Front page strip 19.5 X 5.0 ` 150,000

Inside Front Cover 24.5 X 17.5 ` 100,000

Front Solus Quarter 14.5 X 11.0 ` 100,000

Back Cover 24.5 X 17.5 ` 1, 50,000

Inside Back Cover 24.5 X 17.5 ` 100,000

Full Page 4 Color 24.5 X 17.5 ` 40,000

Half page 4 Color 12.25 X 17.5 ` 25,000

Full Page 2 Color 24.5 X 17.5 ` 30,000

Half Page 2 Color 12.5 X 17.5 ` 20,000

B/W Full Page 24.5 X 17.5 ` 15,000

B/W Half Page 12.25 X 17.5 ` 12,000

Utility Corner 4 Color Quarter 7.0 X 5.0 ` 50,000

IJCP Health Information Products

Dr. Good Dr. Bad

Dr Good Dr Bad is a copyrighted cartoon

based product of IJCP, which depicts
a clinical situation that a doctor might
Situation : A 30-year-old female with a diabetic mother came for
come across and the correct way to deal
a check-up.
with it, in the form of caricatures. The
clinical lesson is supported by a scientific
reference.
You cannot
You are also at risk
of heart disease be at risk A Ready Reckoner, which a doctor
may refer to, when he encounters a
clinical situation that may be difficult to
handle.

Specifications
© IJCP GROUP

LeSSon : As per results of the Fremantle Diabetes Study, a maternal
family history of diabetes confers relative protection against  Size: 4.0 x 5.5 inches or 8”x5.5” inches
cardiovascular disease in female patients but not in male
patients with type 2 diabetes. Paternal family history is
associated with risks equivalent to those without a family  Pages: 20 + 4/ 52+4
history of diabetes.
Diabetes Care 2010;33(7):1477-83.  Paper: Inside - 90 GSM Maplitho
Cover - 250 GSM Art Card/Hardbound
Dr. KK Aggarwal
 Printing: 4+2 Color
 Binding: Centre stitch/Hardbound/Perfect
binding

Handbooks

ECG F ormulaE
IJCP’s Handbooks are a highly coveted
academic gifts for doctors. Covering
Indications of ECG
The main indications are for the evaluation of various topics of relevance to clinicians,
1. The electric axis of the heart these Handbooks give a complete insight
2. Heart rate monitoring
3. Arrhythmias
on the subject discussed therein.
a. Supra ventricular arrhythmias
b. Ventricular arrhythmias An ideal companion to doctors, Handbooks
c. Disorders in the activation sequence- AV
conduction defects
have a long shelf life.
d. Bundle-branch block
e. Wolff-Parkinson-White syndrome
4. Increase in wall thickness or size of the atria and
ventricles
a) Atrial enlargement (hypertrophy)
b) Ventricular enlargement (hypertrophy)
5. Myocardial ischemia and infarction
a. Ischemia
b . Infarction
6. Drug effect
a Digitalis
b. Quinidine Specifications
7. Electrolyte imbalance
a. Potassium
b. Calcium  Size: 7 x 4.5 inches
8. Carditis
a. Pericarditis  Pages: 32-56 +4 pages
b. Myocarditis
9. Pacemaker monitoring  Paper: 210/90 GSM Indian Art Paper
 Printing: 4+2 color offset printing

 Binding: Centre stitch/ perfect binding

IJCP Group's journey from one medical journal to a leading healthcare communications group

IJCP Group's journey from one medical journal to a leading healthcare communications group

Recommended

Recommended

More Related Content

Similar to IJCP Group's journey from one medical journal to a leading healthcare communications group

Similar to IJCP Group's journey from one medical journal to a leading healthcare communications group (20)

Recently uploaded

Recently uploaded (20)

IJCP Group's journey from one medical journal to a leading healthcare communications group